The treatment of urinary tract infections and use of ciprofloxacin extended release

Expert Opinion on Investigational Drugs
Adam D Hickerson, Culley Carson

Abstract

Urinary tract infections (UTIs) are one of the most common reasons people seek medical attention. There are > 50% of women who will have at least one UTI during their lifetime and most of these will require a physician visit and antibiotic treatment. The high prevalence continues to the in-patient setting where genitourinary infections are the most common nosocomial infection. The efficient diagnosis and effective treatment of UTIs is a major healthcare concern. Factors such as economic efficiency and emerging resistance are increasingly becoming more important considerations in providing patient care. In out-patient uncomplicated UTIs, Escherichia coli has been implicated in < or = 75-90% of cases. Although the prevalence in the in-patient setting decreases, E. coli is still the most common bacteria identified and present in 21-54% of urinary isolates. Trimethoprim-sulfamethoxazole has been the preferred first-line agent for uncomplicated out-patient UTIs where local resistance is < 10 - 20%. In recent years, resistance has superseded this threshold in most regions of the US and Europe. In these areas with increased resistance, fluoroquinolones have become a common first-line agent. Ciprofloxacin has been one of the most widel...Continue Reading

References

Oct 1, 1991·Annals of Emergency Medicine·J M SpiveyD E Nix
Mar 1, 1990·Diagnostic Microbiology and Infectious Disease·T Bergan
Nov 1, 1985·American Journal of Public Health·B Foxman, R R Frerichs
Feb 1, 1972·Postgraduate Medical Journal·C E Mabeck
May 1, 1984·The Journal of Antimicrobial Chemotherapy·W Brumfitt, J M Hamilton-Miller
Oct 6, 1997·Infectious Disease Clinics of North America·C Svanborg, G Godaly
Oct 6, 1997·Infectious Disease Clinics of North America·A Stapleton, W E Stamm
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W WarrenW E Stamm
Feb 24, 2001·International Journal of Antimicrobial Agents·P C Appelbaum, P A Hunter
Dec 26, 2001·European Urology·K G NaberUNKNOWN Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R RazUNKNOWN Israeli Urinary Tract Infection Group
Jun 28, 2002·Scandinavian Journal of Primary Health Care·Thierry C M ChristiaensAnders Baerheim
Jul 13, 2002·The American Journal of Medicine·Allan Ronald
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yasmin Khaliq, George G Zhanel
Sep 25, 2003·Antimicrobial Agents and Chemotherapy·Patricia Komp LindgrenDiarmaid Hughes
Oct 7, 2003·International Journal of Antimicrobial Agents·Thomas M Hooton
Dec 10, 2003·Journal of Medical Microbiology·Feng-Jui ChenHsiu-Jung Lo
Dec 23, 2003·The Pediatric Infectious Disease Journal·Martin A KoylePeter D Furness
Jan 24, 2004·The European Respiratory Journal·D SteigerJ D Leuppi
Mar 24, 2004·International Journal of Antimicrobial Agents·David A TalanDavid Elkharrat
Mar 31, 2004·The Medical Clinics of North America·Sean P McLaughlin, Culley C Carson
May 20, 2004·The Annals of Pharmacotherapy·Karla M KillgoreB Joseph Guglielmo
May 25, 2004·Antimicrobial Agents and Chemotherapy·Alison K MeagherJerome J Schentag
Sep 15, 2004·International Journal of Antimicrobial Agents·Tetsuro Muratani, Tetsuro Matsumoto
Jan 22, 2005·Current Allergy and Asthma Reports·Kathrin Scherer, Andreas J Bircher
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J-I AlósJ Perianes
Feb 25, 2005·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kiyohito IshikawaKiyotaka Hoshinaga
Mar 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Van BambekeP M Tulkens
Mar 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A MahamatA Sotto
Apr 15, 2005·Emerging Infectious Diseases·Jesús OteoUNKNOWN Spanish members of EARSS
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Manu Prabhakar, Andrew D Krahn

❮ Previous
Next ❯

Citations

Jun 19, 2010·Journal of Veterinary Pharmacology and Therapeutics·B San MartinF Andre
Mar 7, 2020·International Journal of Preventive Medicine·Seyed Abdol Reza Mortazavi-TabatabaeiIraj Pakzad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.